What Stanford Stroke Center does

Stanford Stroke Center is a specialized clinical and research center within Stanford University School of Medicine's Department of Neurology and Neurosurgery, established in 1992. It provides comprehensive stroke care — including emergency treatment, endovascular thrombectomy, hospitalization, and post-stroke rehabilitation — through the Marc and Laura Andreessen Adult Emergency Department and Stanford Health Care's integrated clinic network, serving acute stroke patients across California primarily through regional referrals. The center also conducts translational and basic science research on stroke mechanisms, prevention, and recovery, building on Stanford's pioneering work in neural stem cell therapy, the CLARITY hydrogel brain imaging technique, and optogenetics.

The center's underlying technology stack is research-oriented rather than productized: it includes the Phase 2 RESCUE trial platform evaluating RNS60 combined with endovascular thrombectomy for acute ischemic stroke, foundational discoveries in stem cell navigation to stroke-damaged brain tissue, and access to Stanford-developed imaging and optogenetic tools. Operations are embedded in Stanford Medicine, an integrated academic health system comprising the School of Medicine, Stanford Health Care, and Lucile Packard Children's Hospital Stanford, with 1,276 postdoctoral scholars and 1,257 residents and clinical fellows supporting research and training throughput.

As a non-commercial academic center within a private nonprofit university, the center does not report standalone revenue. Its underlying economics are supported by clinical care billing through Stanford Health Care, federal and private research grants (Stanford School of Medicine received $381 million in NIH funding in 2016, the highest per-researcher ratio in the country), tuition from MD, PhD, MS, and postdoctoral programs, and technology transfer and licensing of research discoveries. The go-to-market motion is sales-led through physician and health network referrals, supplemented by event-driven presence at major neurology conferences and academic publication channels.

Name

Stanford Stroke Center

Legal name

Stanford Stroke Center

Website

https://med.stanford.edu

Company type

Private

Founded year

1885

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Stanford Stroke Center is a clinical and research center within Stanford University School of Medicine that delivers comprehensive stroke care, runs translational neuroscience research, and trains medical professionals through an integrated academic health system.

Ownership category

akta.pro rank

Product category

Stroke Care and Neurology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

akta.pro primary industry

Stroke & Vascular Neurology (HLAKAIAG)

akta.pro secondary industries

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)

Keywords

• Stroke treatment services
• Neurology clinical research
• Academic medical center
• Clinical trials stroke
• Neuroscience research

Headquarters

HQ city

Stanford

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Clinical Care Revenue: Revenue generated from patient care services including emergency stroke treatment, hospitalization, surgical procedures, and follow-up care through Stanford Health Care system
2. Research Grants and NIH Funding: Federal and private research funding including NIH grants, with $381 million total NIH funding (2016) and highest funding per researcher ratio in the country
3. Educational Programs: MD program tuition, PhD programs, continuing medical education, and residency/fellowship training programs
4. Technology Transfer and Licensing: Commercialization of research discoveries through patents, licensing agreements, and technology transfer from Stanford's innovations

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

The Stanford Stroke Center is a specialized clinical and research center within Stanford Medicine's Neurology and Neurosurgery departments focused on stroke prevention, treatment, and recovery. It delivers comprehensive stroke care, conducts clinical research including trials for novel agents such as RNS60 for acute ischemic stroke, and operates within Stanford's academic medical research ecosystem for translational medicine applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Stanford Stroke Center A specialized clinical and research center within Stanford Medicine's Neurology and Neurosurgery departments focused on stroke prevention, treatment, and recovery. The center provides comprehensive stroke care and conducts clinical research.
• Phase 2 RESCUE Trial of RNS60 Clinical trial service for acute ischemic stroke patients investigating the RNS60 therapeutic agent in combination with endovascular thrombectomy to improve stroke outcomes.
• Acute Stroke Emergency Care 24/7 acute stroke care delivered through the Marc and Laura Andreessen Adult Emergency Department at Stanford Health Care, including emergency triage, imaging, and endovascular thrombectomy.
• Stroke Rehabilitation and Prevention Clinics Outpatient stroke follow-up, rehabilitation, and prevention services delivered through Stanford Neurology Clinics within the Stanford Health Care network.

Quantifiable outcome

• First adult human heart transplant in the United States (1968)
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• RevalesiocoreStrategic or Co-development Partner · 21 October 2025Revalesio is presenting data from its Phase 2 RESCUE trial of RNS60 at the 17th World Stroke Congress in Barcelona, Spain (October 22-24, 2025). The Stanford Stroke Center is involved in clinical research studying RNS60's potential to improve outcomes in acute ischemic stroke, especially when combined with endovascular thrombectomy.

Scale indicators11 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Mayo Clinic Stroke Center: Top-tier academic medical center operating a comprehensive stroke program integrating neurology, neurosurgery, and rehabilitation. Comparable to Stanford in faculty caliber, NIH-funded research portfolio, and integrated care delivery model.
• Columbia/NYP Comprehensive Stroke Center: Columbia University and NewYork-Presbyterian operate a comprehensive stroke center with acute intervention, research, and rehabilitation services. Comparable academic standing and research intensity to Stanford.
• NYU Langone Health Stroke Program: NYU Langone's stroke program is part of a major academic medical center with active NIH-funded research and comprehensive clinical services. Directly comparable in scope and academic standing.
• Cleveland Clinic Cerebrovascular Center: Specialized cerebrovascular program within a leading AMC, offering acute stroke care, endovascular therapy, and clinical research. Closely comparable to Stanford Stroke Center in clinical scope and research intensity.
• Mount Sinai Stroke Center: Icahn School of Medicine at Mount Sinai operates a major comprehensive stroke program with strong clinical trials infrastructure and acute care capabilities. Comparable in AMC-tier research and clinical offerings.
• Johns Hopkins Comprehensive Stroke Center: Johns Hopkins-affiliated comprehensive stroke center with deep research portfolio and acute care capabilities. Comparable in academic standing, NIH funding scale, and translational research focus.
• UCSF Neurovascular & Stroke Center: UCSF's stroke program is a Bay Area peer with similar academic medical center structure, research portfolio, and clinical care continuum. Directly comparable geographically and in tier of academic standing.
• Cedars-Sinai Stroke Center: California-based academic medical center with a comprehensive stroke program providing acute care, clinical research, and rehabilitation. Comparable to Stanford in regional footprint and AMC structure.
• Massachusetts General Hospital Stroke Service: Harvard-affiliated academic medical center with a major comprehensive stroke program offering acute intervention, clinical trials, and translational neuroscience research. Directly comparable to Stanford Stroke Center in scope, academic standing, and research output.
• UCLA Health Stroke Center: UCLA's comprehensive stroke center operates within an academic medical system serving California patients with acute stroke care and clinical research. Comparable to Stanford in regional footprint and AMC structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/StanfordMed
• YouTubeyoutube.com/user/stanfordmedicine
• Facebookfacebook.com/stanfordmedicine
• LinkedInlinkedin.com/company/stanford-university-school-of-medicine
• Instagraminstagram.com/stanford.med

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stanford Stroke Center